Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. International most cancers statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 nations. CA Most cancers J Clin. 2021;71:209–49.
Siegel RL, Miller KD, Jemal A. Most cancers statistics, 2020. CA Most cancers J Clin. 2020;70:7–30.
Radu AF, Bungau SG. Administration of rheumatoid arthritis: an outline. Cells. 2021;10:2857.
Aihaiti Y, Track Cai Y, Tuerhong X, Ni Yang Y, Ma Y, Shi Zheng H, et al. Therapeutic results of naringin in rheumatoid arthritis: community pharmacology and experimental validation. Entrance Pharm. 2021;12:672054.
Li J, Yin L, Qi X, Huang Y. Serum sulfatide as a biomarker of carotid atherosclerosis in sufferers with rheumatoid arthritis. Clin Chim Acta. 2022;534:6–13.
Isomäki HA, Hakulinen T, Joutsenlahti U. Extra danger of lymphomas, leukemia and myeloma in sufferers with rheumatoid arthritis. J Power Dis. 1978;31:691–6.
Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S. Incidence of malignancy in grownup sufferers with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther. 2015;17:212.
Smitten AL, Simon TA, Hochberg MC, Suissa S. A meta-analysis of the incidence of malignancy in grownup sufferers with rheumatoid arthritis. Arthritis Res Ther. 2008;10:R45.
Warren GW, Cummings KM. Tobacco and lung most cancers: dangers, developments, and outcomes in sufferers with most cancers. Am Soc Clin Oncol Educ Ebook. 2013;359–64.
Chatzidionysiou Ok, di Giuseppe D, Soderling J, Catrina A, Askling J. Danger of lung most cancers in rheumatoid arthritis and in relation to autoantibody positivity and smoking. RMD Open. 2022;8:e002465.
Kelmenson LB, Demoruelle MK, Deane KD. The advanced function of the lung within the pathogenesis and medical outcomes of rheumatoid arthritis. Curr Rheumatol Rep. 2016;18:69.
Gibiot Q, Monnet I, Levy P, Brun AL, Antoine M, Chouaïd C, et al. Interstitial lung illness related to lung most cancers: a case-control research. J Clin Med. 2020;9:700.
Zhang L, Zhao Q, Yuan F, Liu M. Lung most cancers in sufferers with and with out rheumatoid arthritis: a propensity score-matched survival evaluation cohort research. Thorac Most cancers. 2020;11:1406–13.
England BR, Campany M, Sayles H, Roul P, Yang Y, Ganti AK, et al. Associations of serum cytokines and chemokines with the chance of incident most cancers in a potential rheumatoid arthritis cohort. Int Immunopharmacol. 2021;97:107719.
Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell demise nexus linking metabolism, redox biology, and illness. Cell. 2017;171:273–85.
Ren Z, Hu M, Wang Z, Ge J, Zhou X, Zhang G, et al. Ferroptosis-related genes in lung adenocarcinoma: prognostic signature and immune, drug resistance, mutation evaluation. Entrance Genet. 2021;12:672904.
Zhao T, Yang Q, Xi Y, Xie Z, Shen J, Li Z, et al. Ferroptosis in rheumatoid arthritis: a possible therapeutic technique. Entrance Immunol. 2022;13:779585.
Lin Z, Xu Y, Guan L, Qin L, Ding J, Zhang Q, et al. Seven ferroptosis-specific expressed genes are thought of as potential biomarkers for the analysis and remedy of cigarette smoke-induced persistent obstructive pulmonary illness. Ann Transl Med. 2022;10:331.
Zhang A, Yang J, Ma C, Li F, Luo H. Improvement and validation of a strong ferroptosis-related prognostic signature in lung adenocarcinoma. Entrance Cell Dev Biol. 2021;9:616271.
Gu Z, Gu L, Eils R, Schlesner M, Brors B. circlize Implements and enhances round visualization in R. Bioinformatics. 2014;30:2811–2.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment evaluation: a knowledge-based method for decoding genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–50.
Lu T, Zheng Y, Gong X, Lv Q, Chen J, Tu Z, et al. Excessive expression of hyaluronan-mediated motility receptor predicts adversarial outcomes: a possible therapeutic goal for head and neck squamous cell carcinoma. Entrance Oncol. 2021;11:608842.
Tavasolian F, Hosseini AZ, Soudi S, Naderi M, Sahebkar A. A methods biology method for miRNA-mRNA expression patterns evaluation in rheumatoid arthritis. Comb Chem Excessive Throughput Display screen. 2021;24:195–212.
Kumar S, Sharawat SK, Ali A, Gaur V, Malik PS, Kumar S, et al. Identification of differentially expressed circulating serum microRNA for the analysis and prognosis of Indian non-small cell lung most cancers sufferers. Curr Probl Most cancers. 2020;44:100540.
Sparks JA. Rheumatoid arthritis. Ann Intern Med. 2019;170:Itc1–16.
Liu X, Xu Y, Zhou Q, Chen M, Liang H, Zhao J, et al. Clinicopathological options of lung most cancers in sufferers with rheumatoid arthritis. J Thorac Dis. 2018;10:3965–72.
Pundole X, Suarez-Almazor ME. Most cancers and rheumatoid arthritis. Rheum Dis Clin North Am. 2020;46:445–62.
Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, et al. Ferroptosis in most cancers and most cancers immunotherapy. Most cancers Commun (Lond). 2022;42:88–116.
Yin J, Meng X, Peng L, Xie W, Liu X, He W, et al. Ferroptosis and most cancers immunotherapy. Curr Mol Med. 2023;23:401–9.
Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, et al. Power-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020;22:225–34.
Zhao Y, Li M, Yao X, Fei Y, Lin Z, Li Z, et al. HCAR1/MCT1 regulates tumor ferroptosis by the lactate-mediated AMPK-SCD1 exercise and its therapeutic implications. Cell Rep. 2020;33:108487.
Gu Y, Albuquerque CP, Braas D, Zhang W, Villa GR, Bi J, et al. mTORC2 regulates amino acid metabolism in most cancers by phosphorylation of the cystine-glutamate antiporter xCT. Mol Cell. 2017;67:128–138.e7.
Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al. Intercellular interplay dictates most cancers cell ferroptosis by way of NF2-YAP signalling. Nature. 2019;572:402–6.
Lai B, Wu CH, Wu CY, Luo SF, Lai JH. Ferroptosis and autoimmune ailments. Entrance Immunol. 2022;13:916664.
Nalepa G, Clapp DW. Fanconi anaemia and most cancers: an intricate relationship. Nat Rev Most cancers. 2018;18:168–85.
Zheng C, Ren Z, Chen H, Yuan X, Suye S, Yin H, et al. FANCD2 promotes the malignant habits of endometrial most cancers cells and its prognostic worth. Exp Cell Res. 2022;421:113388.
Kuhnert VM, Kachnic LA, Li L, Purschke M, Gheorghiu L, Lee R, et al. FANCD2-deficient human fibroblasts are hypersensitive to ionising radiation at oxygen concentrations of 0% and three% however not underneath normoxic circumstances. Int J Radiat Biol. 2009;85:523–31.
Geiman TM, Muegge Ok. Lsh, an SNF2/helicase member of the family, is required for proliferation of mature T lymphocytes. Proc Natl Acad Sci USA. 2000;97:4772–7.
Schuller S, Sieker J, Riemenschneider P, Köhler B, Drucker E, Weiler SME, et al. HELLS is negatively regulated by wild-type P53 in liver most cancers by a mechanism involving P21 and FOXM1. Cancers (Basel). 2022;14:459.
Solar H, Yang B, Zhang H, Track J, Zhang Y, Xing J, et al. RRM2 is a possible prognostic biomarker with purposeful significance in glioma. Int J Biol Sci. 2019;15:533–43.
Kotaka M, Gover S, Vandeputte-Rutten L, Au SW, Lam VM, Adams MJ. Structural research of glucose-6-phosphate and NADP+ binding to human glucose-6-phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr. 2005;61:495–504.
Dlugosz P, Tresky R, Nimpf J. Differential motion of reelin on oligomerization of ApoER2 and VLDL receptor in HEK293 cells assessed by time-resolved anisotropy and fluorescence lifetime imaging microscopy. Entrance Mol Neurosci. 2019;12:53.
Pauley KM, Cha S, Chan EK. MicroRNA in autoimmunity and autoimmune ailments. J Autoimmun. 2009;32:189–94.
Esquela-Kerscher A, Slack FJ. Oncomirs – microRNAs with a job in most cancers. Nat Rev Most cancers. 2006;6:259–69.
Track Y, Kelava L, Kiss I. MiRNAs in lung adenocarcinoma: function, analysis, prognosis, and remedy. Int J Mol Sci. 2023;24:13302.
Meng T, Liu J, Chang H, Qie R. Reverse predictive evaluation of Rhizoma Pinelliae and Rhizoma Coptidis on differential miRNA goal genes in lung adenocarcinoma. Medication (Baltimore). 2023;102:e32999.
Withrow J, Murphy C, Liu Y, Hunter M, Fulzele S, Hamrick MW. Extracellular vesicles within the pathogenesis of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2016;18:286.
Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Homosexual RE, et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58:1001–9.
Daraghmeh DN, King C, Wiese MD. A assessment of liquid biopsy as a software to evaluate epigenetic, cfDNA and miRNA variability as methotrexate response predictors in sufferers with rheumatoid arthritis. Pharm Res. 2021;173:105887.
Zhou X, Zhang Z, Liang X. Regulatory community evaluation to disclose essential miRNAs and genes in non-small cell lung most cancers. Cell J. 2020;21:459–66.
Ormseth MJ, Solus JF, Vickers KC, Oeser AM, Raggi P, Stein CM. Utility of choose plasma MicroRNA for illness and cardiovascular danger evaluation in sufferers with rheumatoid arthritis. J Rheumatol. 2015;42:1746–51.
La Fleur L, Falk-Sörqvist E, Smeds P, Berglund A, Sundström M, Mattsson JS, et al. Mutation patterns in a population-based non-small cell lung most cancers cohort and prognostic impression of concomitant mutations in KRAS and TP53 or STK11. Lung Most cancers. 2019;130:50–58.
West HJ, McCleland M, Cappuzzo F, Reck M, Mok TS, Jotte RM, et al. Scientific efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung most cancers with STK11, KEAP1, or TP53 comutations: subgroup outcomes from the part III IMpower150 trial. J Immunother Most cancers. 2022;10:e003027.
Jiang M, Jia Ok, Wang L, Li W, Chen B, Liu Y, et al. Alterations of DNA harm response pathway: Biomarker and therapeutic technique for most cancers immunotherapy. Acta Pharm Sin B. 2021;11:2983–94.
Gansmo LB, Lie BA, Mæhlen MT, Vatten L, Romundstad P, Hveem Ok, et al. Polymorphisms within the TP53-MDM2-MDM4-axis in sufferers with rheumatoid arthritis. Gene. 2021;793:145747.
Wu H, Zhou X, Wang X, Cheng W, Hu X, Wang Y, et al. miR-34a in extracellular vesicles from bone marrow mesenchymal stem cells reduces rheumatoid arthritis irritation by way of the cyclin I/ATM/ATR/p53 axis. J Cell Mol Med. 2021;25:1896–910.
Mensah KA, Chen JW, Schickel JN, Isnardi I, Yamakawa N, Vega-Loza A, et al. Impaired ATM activation in B cells is related to bone resorption in rheumatoid arthritis. Sci Transl Med. 2019;11.
Xu D, Chu M, Chen Y, Fang Y, Wang J, Zhang X, et al. Identification and verification of ferroptosis-related genes within the pathology of epilepsy: insights from CIBERSORT algorithm evaluation. Entrance Neurol. 2023;14:1275606.
Hao D, Han G, Sinjab A, Gomez-Bolanos LI, Lazcano R, Serrano A, et al. The one-cell immunogenomic panorama of B and plasma cells in early-stage lung adenocarcinoma. Most cancers Discov. 2022;12:2626–45.
Komatsu N, Win S, Yan M, Huynh NC, Sawa S, Tsukasaki M, et al. Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis. J Clin Make investments. 2021;131:e143060.
Murray PJ. Macrophage polarization. Annu Rev Physiol. 2017;79:541–66.
Sinjab A, Han G, Treekitkarnmongkol W, Hara Ok, Brennan PM, Dang M, et al. Resolving the spatial and mobile structure of lung adenocarcinoma by multiregion single-cell sequencing. Most cancers Discov. 2021;11:2506–23.
Udalova IA, Mantovani A, Feldmann M. Macrophage heterogeneity within the context of rheumatoid arthritis. Nat Rev Rheumatol. 2016;12:472–85.
Weyand CM, Goronzy JJ. The immunology of rheumatoid arthritis. Nat Immunol. 2021;22:10–18.
Huang Z, Li B, Guo Y, Wu L, Kou F, Yang L. Signatures of multi-omics reveal distinct tumor immune microenvironment contributing to immunotherapy in lung adenocarcinoma. Entrance Immunol. 2021;12:723172.
Hu XX, Wu YJ, Zhang J, Wei W. T-cells work together with B cells, dendritic cells, and fibroblast-like synoviocytes as hub-like key cells in rheumatoid arthritis. Int Immunopharmacol. 2019;70:428–34.
Bao X, Shi R, Zhao T, Wang Y. Mast cell-based molecular subtypes and signature related to medical consequence in early-stage lung adenocarcinoma. Mol Oncol. 2020;14:917–32.
Rivellese F, Rossi FW, Galdiero MR, Pitzalis C, de Paulis A. Mast cells in early rheumatoid arthritis. Int J Mol Sci. 2019;20:2040.
Shan G, Bi G, Bian Y, Valeria B, Zeng D, Zhang H, et al. Genomic and tumor microenvironment variations between cell cycle development pathway altered/non-altered sufferers with lung adenocarcinoma. Entrance Oncol. 2022;12:843528.
Rana AK, Li Y, Dang Q, Yang F. Monocytes in rheumatoid arthritis: circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity function in RA pathogenesis. Int Immunopharmacol. 2018;65:348–59.
Miao H, Ren Q, Li H, Zeng M, Chen D, Xu C, et al. Complete evaluation of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma. BMC Most cancers. 2022;22:225.
Zhu W, Li LL, Songyang Y, Shi Z, Li D. Identification and validation of HELLS (Helicase, Lymphoid-Particular) and ICAM1 (Intercellular adhesion molecule 1) as potential diagnostic biomarkers of lung most cancers. PeerJ. 2020;8:e8731.
Luo L, Chen X, Huang F. Machine studying revealed ferroptosis options and ferroptosis-related gene-based immune microenvironment in lung adenocarcinoma. Chem Biol Work together. 2023;378:110471.
Jiang X, Li Y, Zhang N, Gao Y, Han L, Li S, et al. RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity by way of activating cGAS/STING signaling pathway in lung adenocarcinoma. Cell Biosci. 2021;11:74.
Jiang J, Huang D, Jiang Y, Hou J, Tian M, Li J, et al. Lactate modulates mobile metabolism by histone lactylation-mediated gene expression in non-small cell lung most cancers. Entrance Oncol. 2021;11:647559.
Kim BK, Yoo HI, Lee AR, Choi Ok, Yoon SK. Decreased expression of VLDLR is inversely correlated with miR-200c in human colorectal most cancers. Mol Carcinog. 2017;56:1620–9.
Hays LE, Zodrow DM, Yates JE, Deffebach ME, Jacoby DB, Olson SB, et al. Cigarette smoke induces genetic instability in airway epithelial cells by suppressing FANCD2 expression. Br J Most cancers. 2008;98:1653–61.
Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL. Patterns of interstitial lung illness and mortality in rheumatoid arthritis. Rheumatol (Oxf). 2017;56:344–50.
Mavragani CP, Nezos A, Sagalovskiy I, Seshan S, Kirou KA, Crow MK. Faulty regulation of L1 endogenous retroelements in major Sjogren’s syndrome and systemic lupus erythematosus: Position of methylating enzymes. J Autoimmun. 2018;88:75–82.
Wu B, Peng R, Chen Y, Zhong J, Zhong S, Wang B, et al. Identification of RRM2 in peripheral blood mononuclear cells as a novel biomarker for the analysis of rheumatoid arthritis. Clin Exp Rheumatol. 2022;40:2109–18.
Gheita TA, Kenawy SA, El Sisi RW, Gheita HA, Khalil H. Subclinical lowered G6PD exercise in rheumatoid arthritis and Sjögren’s Syndrome sufferers: relation to medical traits, illness exercise and metabolic syndrome. Mod Rheumatol. 2014;24:612–7.
Abramova I, Park Ok, Hosny C, Tuladhar S, Yao Q, Patnaik A. A research on the relevance of glucose-6-phosphate dehydrogenase stage screening in sufferers with rheumatic ailments previous to initiating remedy with hydroxychloroquine. Cureus. 2020;12:e9519.
